• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza A: in the province were vaccinated almost 100% of the risk groups

Tonka

New member
http://www.infobae.com/salud/523009...incia-se-vacuno-casi-el-100-los-grupos-riesgo

06/25/1910 | HEALTH
Influenza A: in the province were vaccinated almost 100% of the risk groups by Barbara Roesler
Aires Health Minister, Alexander Collie, told Infobae.com immunization was achieved over 97% of those most vulnerable to influenza A. "It's a historical fact," he said

Dialogue with the minister confirmed that vaccination in the province exceeded the goal set by the national health portfolio with respect to the A/H1N1 influenza vaccination in risk groups, which was 80 percent of its members.

"We are above the national average (current), which is 87%.. (...) We are now in 97%," stressed the official. He added that this figure may be even higher if one considers that the data entry process "is delayed for ten days or so."

For Collie, this is a fact, but significant milestone in the Province.

Vaccination almost 100% of the members of risk groups and the growing awareness by the population of the preventive measures to be taken into account to avoid contracting the disease influenced, of course, the reduction of both infections H1N1 influenza and the other serious respiratory diseases are usually recorded at this time of year.

In this regard, the minister stressed the sharp decline in cases of this kind of evils compared to the same week of 2009. As listed, so far this year 4,000 cases were registered under bronchiolitis (respiratory syncytial virus with again as a major contributor to the disease), 2,000 patients with pneumonia and 40,000 less than seasonal flu infected.

With regard to influenza A/H1N1, Collie confirmed that in the first six months of 2010, only six cases were reported, unlike the 114 accounted for this time last year. "The decline is almost 95%," he said.

The last cases detected within these half-dozen patients were diagnosed positive towards the middle of April, "so 50 days ago, or two months, the province is no viral circulation," said the official.

For his part, Luis Crovetto, director of Preventive Medicine of Buenos Aires, said the H1N1 flu vaccination among pregnant women is higher than 80%, "which reached levels similar to the implementation of the first dose in children under 3 years. Notwithstanding the encouraging data, mothers recalled the importance of bringing children to the vaccination to receive the second dose of the drug.

In this regard, said that one of the reasons why it is still difficult to achieve an optimal level of second immunization in children is that almost no virus circulation in the Province "relaxing a little mothers" who believe it is necessary closer to implementing the booster at 21 days of the first dose.

"The application of the two doses would allow immunity for longer than that offered by the flu vaccine, which mutates every year," said Crovetto.

The vaccination campaign against influenza A/H1N1 oriented to coverage of risk groups (who recently joined the moderate asthmatics ago, the caretakers of children under six months, the entry-level teachers and relatives of patients cancer) will run until August. Until then, the stock of both drugs for pregnant women and for children under three years "is warranted," said the director.
 
Back
Top Bottom